These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 3900840)
1. Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Malini S; Smith EO; Goldzieher JW Obstet Gynecol; 1985 Oct; 66(4):538-41. PubMed ID: 3900840 [TBL] [Abstract][Full Text] [Related]
2. Effect of combined oral contraceptives on breast epithelial proliferation in young women. Garcia y Narvaiza D; Navarrete MA; Falzoni R; Maier CM; Nazário AC Breast J; 2008; 14(5):450-5. PubMed ID: 18657146 [TBL] [Abstract][Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
4. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study]. Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608 [TBL] [Abstract][Full Text] [Related]
5. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674 [TBL] [Abstract][Full Text] [Related]
7. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women]. Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study of a low-dose contraceptive--Femodene]. Rachev E; Damianov L; Dukovski A; Katsarova M Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249 [TBL] [Abstract][Full Text] [Related]
9. Cycle control and side effects of a new combiphasic oral contraceptive regimen. Dieben TO; op ten Berg MT; Coelingh Bennink HJ Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial on the impact of starting day on ovarian follicular activity in very low dose oral contraceptive pills users. Sitavarin S; Jaisamrarn U; Taneepanichskul S J Med Assoc Thai; 2003 May; 86(5):442-8. PubMed ID: 12859101 [TBL] [Abstract][Full Text] [Related]
11. Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion. Schleussner E; Brueckner T; Brautigam J; Michels W Gynecol Endocrinol; 2001 Aug; 15(4):259-64. PubMed ID: 11560098 [TBL] [Abstract][Full Text] [Related]
12. Rationale for a triphasic oral contraceptive. Pasquale SA J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710 [TBL] [Abstract][Full Text] [Related]
13. The interaction between St John's wort and an oral contraceptive. Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455 [TBL] [Abstract][Full Text] [Related]